{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:38:54Z","timestamp":1791401934525,"version":"4.3.3"},"reference-count":258,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-05967-w","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T05:49:10Z","timestamp":1780120150000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["3-Nitropropionic Acid\u2013Induced Huntington\u2019s Disease in Preclinical Models: Mechanisms, Peripheral Toxicities, Model Gaps, and Future Directions"],"prefix":"10.1007","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1407-4906","authenticated-orcid":false,"given":"Harikrishna Reddy","family":"Dontiboina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4976-5892","authenticated-orcid":false,"given":"Srikanth","family":"Yadava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5509-6925","authenticated-orcid":false,"given":"Venkata Prasuja","family":"Nakka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2733-6909","authenticated-orcid":false,"given":"Naresh","family":"Dumala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2726-130X","authenticated-orcid":false,"given":"Matte Kasi","family":"Viswanadh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3777-3157","authenticated-orcid":false,"given":"Chakravarthi","family":"Guntupalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2912-5213","authenticated-orcid":false,"given":"Buchi N.","family":"Nalluri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3069-5742","authenticated-orcid":false,"given":"Narender","family":"Malothu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5634-6006","authenticated-orcid":false,"given":"Ganesh","family":"Yadagiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7654-5875","authenticated-orcid":false,"given":"Lohitha","family":"Gujjari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2067-1410","authenticated-orcid":false,"given":"Kakarla","family":"Ramakrishna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,30]]},"reference":[{"issue":"9557","key":"5967_CR1","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","volume":"369","author":"FO Walker","year":"2007","unstructured":"Walker FO (2007) Huntington\u2019s disease. Lancet 369(9557):218\u2013228","journal-title":"Lancet"},{"issue":"6","key":"5967_CR2","doi-asserted-by":"publisher","first-page":"807","DOI":"10.3390\/genes15060807","volume":"15","author":"M Pengo","year":"2024","unstructured":"Pengo M, Squitieri F (2024) Beyond CAG repeats: the multifaceted role of genetics in Huntington disease. Genes Basel 15(6):807","journal-title":"Genes Basel"},{"issue":"4","key":"5967_CR3","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.3233\/JAD-191032","volume":"76","author":"Z Sun","year":"2020","unstructured":"Sun Z, Sun L, Tu L (2020) GABA B receptor-mediated PI3K\/Akt signaling pathway alleviates oxidative stress and neuronal cell injury in a rat model of Alzheimer\u2019s disease. J Alzheimers Dis 76(4):1513\u20131526","journal-title":"J Alzheimers Dis"},{"issue":"1\u20132","key":"5967_CR4","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.brainresbull.2005.06.024","volume":"67","author":"M Tariq","year":"2005","unstructured":"Tariq M et al (2005) Neuroprotective effect of nicotine against 3-nitropropionic acid (3-NP)-induced experimental Huntington\u2019s disease in rats. Brain Res Bull 67(1\u20132):161\u2013168","journal-title":"Brain Res Bull"},{"issue":"1","key":"5967_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.expneurol.2011.12.013","volume":"238","author":"M Arrasate","year":"2012","unstructured":"Arrasate M, Finkbeiner S (2012) Protein aggregates in Huntington\u2019s disease. Exp Neurol 238(1):1\u201311","journal-title":"Exp Neurol"},{"issue":"1","key":"5967_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2015.5","volume":"1","author":"GP Bates","year":"2015","unstructured":"Bates GP et al (2015) Huntington disease. Nat Rev Dis Primers 1(1):1\u201321","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"5967_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10048-025-00801-2","volume":"26","author":"OK Kunwar","year":"2025","unstructured":"Kunwar OK, Singh S (2025) Neuroinflammation and neurodegeneration in Huntington\u2019s disease: genetic hallmarks, role of metals and organophosphates. Neurogenetics 26(1):1\u201315","journal-title":"Neurogenetics"},{"issue":"3","key":"5967_CR8","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1159\/000524732","volume":"56","author":"A Exuzides","year":"2022","unstructured":"Exuzides A et al (2022) Epidemiology of Huntington\u2019s disease in the United States Medicare and Medicaid populations. Neuroepidemiology 56(3):192\u2013200","journal-title":"Neuroepidemiology"},{"issue":"1","key":"5967_CR9","first-page":"78","volume":"59","author":"S Chen","year":"2025","unstructured":"Chen S et al (2025) Sex-specific differences in the progression of Huntington\u2019s disease symptoms\u2013a national study in China. Neuroepidemiology 59(1):78\u201386","journal-title":"Neuroepidemiology"},{"issue":"1","key":"5967_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2024.105304","volume":"26","author":"AC Ogilvie","year":"2025","unstructured":"Ogilvie AC et al (2025) Exploring place of death among individuals with Huntington\u2019s disease in the United States. J Am Med Dir Assoc 26(1):105304","journal-title":"J Am Med Dir Assoc"},{"issue":"12","key":"5967_CR11","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1002\/mds.29228","volume":"37","author":"A Medina","year":"2022","unstructured":"Medina A et al (2022) Prevalence and incidence of Huntington\u2019s disease: an updated systematic review and meta-analysis. Mov Disord 37(12):2327\u20132335","journal-title":"Mov Disord"},{"key":"5967_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1172-5-40","volume":"5","author":"RA Roos","year":"2010","unstructured":"Roos RA (2010) Huntington\u2019s disease: a clinical review. Orphanet J Rare Dis 5:1\u20138","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"5967_CR13","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1176\/jnp.17.4.496","volume":"17","author":"JS Paulsen","year":"2005","unstructured":"Paulsen JS et al (2005) Depression and stages of Huntington\u2019s disease. J Neuropsychiatry Clin Neurosci 17(4):496\u2013502","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"2","key":"5967_CR14","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1001\/archneur.58.2.273","volume":"58","author":"SC Kirkwood","year":"2001","unstructured":"Kirkwood SC et al (2001) Progression of symptoms in the early and middle stages of Huntington disease. Arch Neurol 58(2):273\u2013278","journal-title":"Arch Neurol"},{"issue":"1","key":"5967_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/s25010266","volume":"25","author":"A Caroppo","year":"2025","unstructured":"Caroppo A et al (2025) Movement disorders and smart wrist devices: a comprehensive study. Sensors (Basel) 25(1):266","journal-title":"Sensors (Basel)"},{"key":"5967_CR16","first-page":"28","volume":"45","author":"B Kremer","year":"2002","unstructured":"Kremer B (2002) Clinical neurology of Huntington\u2019s disease. Oxf Monogr Med Genet 45:28\u201361","journal-title":"Oxf Monogr Med Genet"},{"issue":"1","key":"5967_CR17","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.neubiorev.2011.06.002","volume":"36","author":"SM Henley","year":"2012","unstructured":"Henley SM et al (2012) Emotion recognition in Huntington\u2019s disease: a systematic review. Neurosci Biobehav Rev 36(1):237\u2013253","journal-title":"Neurosci Biobehav Rev"},{"issue":"2","key":"5967_CR18","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/bjc.12337","volume":"61","author":"M Cavallo","year":"2022","unstructured":"Cavallo M, Sergi A, Pagani M (2022) Cognitive and social cognition deficits in Huntington\u2019s disease differ between the prodromal and the manifest stages of the condition: a scoping review of recent evidence. Br J Clin Psychol 61(2):214\u2013241","journal-title":"Br J Clin Psychol"},{"issue":"1","key":"5967_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2741\/S355","volume":"5","author":"EM Dumas","year":"2013","unstructured":"Dumas EM et al (2013) A review of cognition in Huntington\u2019s disease. Front Biosci (Schol Ed) 5(1):1\u201318","journal-title":"Front Biosci (Schol Ed)"},{"issue":"15","key":"5967_CR20","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.1021\/acs.orglett.4c00758","volume":"26","author":"CW Johnson","year":"2024","unstructured":"Johnson CW, Ohashi M, Tang Y (2024) How fungi biosynthesize 3-nitropropanoic acid: the simplest yet lethal mycotoxin. Org Lett 26(15):3158\u20133163","journal-title":"Org Lett"},{"issue":"9","key":"5967_CR21","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1002\/iub.1195","volume":"65","author":"K Francis","year":"2013","unstructured":"Francis K et al (2013) The biochemistry of the metabolic poison propionate 3-nitronate and its conjugate acid, 3-nitropropionate. IUBMB Life 65(9):759\u2013768","journal-title":"IUBMB Life"},{"key":"5967_CR22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/978-1-59259-692-8_2","volume-title":"Mitochondrial inhibitors and neurodegenerative disorders","author":"BF Hamilton","year":"2000","unstructured":"Hamilton BF, Gould DH, Gustine DL (2000) History of 3-nitropropionic acid. In: Sanberg PR, Nishino H, Borlongan CV (eds) Mitochondrial inhibitors and neurodegenerative disorders. Humana Press, Totowa, NJ, pp 21\u201333"},{"issue":"6","key":"5967_CR23","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1007\/s11064-023-03868-1","volume":"48","author":"S Upadhayay","year":"2023","unstructured":"Upadhayay S et al (2023) An overview of the pathophysiological mechanisms of 3-nitropropionic acid (3-NPA) as a neurotoxin in a Huntington\u2019s disease model and its relevance to drug discovery and development. Neurochem Res 48(6):1631\u20131647","journal-title":"Neurochem Res"},{"issue":"4","key":"5967_CR24","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1017\/S0317167100032212","volume":"18","author":"AC Ludolph","year":"1991","unstructured":"Ludolph AC et al (1991) 3-Nitropropionic acid - exogenous animal neurotoxin and possible human striatal toxin. Canadian Journal of Neurological Sciences \/ Journal Canadien des Sciences Neurologiques 18(4):492\u2013498","journal-title":"Canadian Journal of Neurological Sciences \/ Journal Canadien des Sciences Neurologiques"},{"issue":"3","key":"5967_CR25","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/BF00691103","volume":"72","author":"BF Hamilton","year":"1987","unstructured":"Hamilton BF, Gould DH (1987) Nature and distribution of brain lesions in rats intoxicated with 3-nitropropionic acid: a type of hypoxic (energy deficient) brain damage. Acta Neuropathol 72(3):286\u2013297","journal-title":"Acta Neuropathol"},{"key":"5967_CR26","doi-asserted-by":"crossref","unstructured":"Haider S, Wild E, and Tabrizi SJ (2017) Huntington\u2019s disease and other choreas. Neurodegener, pp 248\u2013283","DOI":"10.1002\/9781118661895.ch21"},{"key":"5967_CR27","unstructured":"Nasr P (2003) 3-nitropropionic acid: a mode for Huntington\u2019s disease.\u00a0University of Kentucky"},{"issue":"12","key":"5967_CR28","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1002\/jnr.24495","volume":"97","author":"ET Koch","year":"2019","unstructured":"Koch ET, Raymond LA (2019) Dysfunctional striatal dopamine signaling in Huntington\u2019s disease. J Neurosci Res 97(12):1636\u20131654","journal-title":"J Neurosci Res"},{"issue":"3","key":"5967_CR29","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1097\/00001756-199502000-00034","volume":"6","author":"MI Behrens","year":"1995","unstructured":"Behrens MI et al (1995) 3-Nitropropionic acid induces apoptosis in cultured striatal and cortical neurons. Neuroreport 6(3):545\u2013548","journal-title":"Neuroreport"},{"key":"5967_CR30","doi-asserted-by":"crossref","unstructured":"Brouillet E (2014) The 3-NP model of striatal neurodegeneration. Curr Protoc Neurosci 67:(9)9\u201348","DOI":"10.1002\/0471142301.ns0948s67"},{"issue":"4","key":"5967_CR31","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1016\/S0002-9440(10)62536-9","volume":"159","author":"KL Gabrielson","year":"2001","unstructured":"Gabrielson KL et al (2001) Mitochondrial toxin 3-nitropropionic acid induces cardiac and neurotoxicity differentially in mice. Am J Pathol 159(4):1507\u20131520","journal-title":"Am J Pathol"},{"issue":"2","key":"5967_CR32","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s10072-010-0394-2","volume":"32","author":"E Hern\u00e1ndez-Echeagaray","year":"2011","unstructured":"Hern\u00e1ndez-Echeagaray E et al (2011) Low doses of 3-nitropropionic acid in vivo induce damage in mouse skeletal muscle. Neurol Sci 32(2):241\u2013254","journal-title":"Neurol Sci"},{"key":"5967_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpc.2020.108772","volume":"234","author":"MT Wiprich","year":"2020","unstructured":"Wiprich MT et al (2020) Influence of 3-nitropropionic acid on physiological and behavioral responses in zebrafish larvae and adults. Comp Biochem Physiol C Toxicol Pharmacol 234:108772","journal-title":"Comp Biochem Physiol C Toxicol Pharmacol"},{"issue":"2","key":"5967_CR34","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/0006-8993(94)90085-X","volume":"646","author":"TK Koutouzis","year":"1994","unstructured":"Koutouzis TK et al (1994) Systemic 3-nitropropionic acid: long-term effects on locomotor behavior. Brain Res 646(2):242\u2013246","journal-title":"Brain Res"},{"key":"5967_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.00930","volume":"9","author":"NP Rocha","year":"2018","unstructured":"Rocha NP et al (2018) The clinical picture of psychosis in manifest Huntington\u2019s disease: a comprehensive analysis of the enroll-HD database. Front Neurol 9:930","journal-title":"Front Neurol"},{"issue":"22","key":"5967_CR36","doi-asserted-by":"publisher","first-page":"e2042","DOI":"10.1212\/WNL.0000000000008541","volume":"93","author":"SK Diehl","year":"2019","unstructured":"Diehl SK et al (2019) Motor speech patterns in Huntington disease. Neurology 93(22):e2042\u2013e2052","journal-title":"Neurology"},{"issue":"1\u20132","key":"5967_CR37","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.brainresbull.2007.12.007","volume":"76","author":"NI Wood","year":"2008","unstructured":"Wood NI et al (2008) Increased thirst and drinking in Huntington\u2019s disease and the R6\/2 mouse. Brain Res Bull 76(1\u20132):70\u201379","journal-title":"Brain Res Bull"},{"issue":"1","key":"5967_CR38","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0306-4522(96)00602-1","volume":"79","author":"M-C Guyot","year":"1997","unstructured":"Guyot M-C et al (1997) Quantifiable bradykinesia, gait abnormalities and Huntington\u2019s disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid. Neuroscience 79(1):45\u201356","journal-title":"Neuroscience"},{"key":"5967_CR39","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3389\/fphys.2014.00380","volume":"5","author":"D Zielonka","year":"2014","unstructured":"Zielonka D et al (2014) Skeletal muscle pathology in Huntington\u2019s disease. Front Physiol 5:380","journal-title":"Front Physiol"},{"issue":"4","key":"5967_CR40","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1177\/18796397241289044","volume":"13","author":"J Petrillo","year":"2024","unstructured":"Petrillo J et al (2024) Cognitive impairment in Huntington\u2019s disease and its impact on functioning: concept elicitation and cognitive debriefing for the Huntington\u2019s disease everyday functioning (Hi-DEF) scale. J Huntington Dis 13(4):511\u2013522","journal-title":"J Huntington Dis"},{"issue":"2","key":"5967_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0117223","volume":"10","author":"ET Menze","year":"2015","unstructured":"Menze ET et al (2015) Genistein improves 3-NPA-induced memory impairment in ovariectomized rats: impact of its antioxidant, anti-inflammatory and acetylcholinesterase modulatory properties. PLoS ONE 10(2):e0117223","journal-title":"PLoS ONE"},{"key":"5967_CR42","doi-asserted-by":"crossref","unstructured":"Murphy CA et al (2014) Cognitive deficits in the R6\/2 model of Huntington\u2019s disease and amelioration with donepezil. Int J Comp Psychol 27(3)","DOI":"10.46867\/ijcp.2014.27.03.08"},{"key":"5967_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1189957","volume":"14","author":"PT Lum","year":"2023","unstructured":"Lum PT et al (2023) Neuroprotective potency of mangiferin against 3-nitropropionic acid induced Huntington\u2019s disease-like symptoms in rats: possible antioxidant and anti-inflammatory mechanisms. Front Pharmacol 14:1189957","journal-title":"Front Pharmacol"},{"issue":"4","key":"5967_CR44","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1176\/appi.neuropsych.14100265","volume":"27","author":"M Dale","year":"2015","unstructured":"Dale M, van Duijn E (2015) Anxiety in Huntington\u2019s disease. J Neuropsychiatry Clin Neurosci 27(4):262\u2013271","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"5967_CR45","doi-asserted-by":"publisher","unstructured":"Bhimanwar AA, Ghaisas MM, and Shete RV (2022) Silymarin, quercetin and hesperidin combination ameliorate learning and memory deficit in 3 nitro propionic acid induced rat model of Huntington\u2019s disease. SSRN Electron J. https:\/\/doi.org\/10.2139\/ssrn.4004056","DOI":"10.2139\/ssrn.4004056"},{"key":"5967_CR46","doi-asserted-by":"publisher","unstructured":"Wiprich MT et al (2024) 3-Nitropropionic acid induces histological and behavioral alterations in adult zebrafish: role of antioxidants on behavioral dysfunction. https:\/\/doi.org\/10.1101\/2024.04.29.591507","DOI":"10.1101\/2024.04.29.591507"},{"issue":"2","key":"5967_CR47","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s12035-023-03584-5","volume":"61","author":"MT Wiprich","year":"2024","unstructured":"Wiprich MT et al (2024) Locomotor behavior and memory dysfunction induced by 3-nitropropionic acid in adult zebrafish: modulation of dopaminergic signaling. Mol Neurobiol 61(2):609\u2013621","journal-title":"Mol Neurobiol"},{"issue":"5","key":"5967_CR48","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/0092-8674(95)90542-1","volume":"81","author":"J Nasir","year":"1995","unstructured":"Nasir J et al (1995) Targeted disruption of the Huntington\u2019s disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes. Cell 81(5):811\u2013823","journal-title":"Cell"},{"issue":"4","key":"5967_CR49","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/ng1297-404","volume":"17","author":"JK White","year":"1997","unstructured":"White JK et al (1997) Huntingtin is required for neurogenesis and is not impaired by the Huntington\u2019s disease CAG expansion. Nat Genet 17(4):404\u2013410","journal-title":"Nat Genet"},{"key":"5967_CR50","doi-asserted-by":"publisher","unstructured":"Chang R et al (2015) Transgenic animal models for study of the pathogenesis of Huntington\u2019s disease and therapy. Drug design, development and therapy 9:2179\u20132188. https:\/\/doi.org\/10.2147\/DDDT.S58470","DOI":"10.2147\/DDDT.S58470"},{"issue":"19","key":"5967_CR51","doi-asserted-by":"publisher","first-page":"3702","DOI":"10.1093\/hmg\/ddq285","volume":"19","author":"MY Heng","year":"2010","unstructured":"Heng MY et al (2010) Early autophagic response in a novel knock-in model of Huntington disease. Hum Mol Genet 19(19):3702\u20133720","journal-title":"Hum Mol Genet"},{"issue":"3","key":"5967_CR52","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1602\/neurorx.2.3.447","volume":"2","author":"JY Li","year":"2005","unstructured":"Li JY, Popovic N, Brundin P (2005) The use of the R6 transgenic mouse models of Huntington\u2019s disease in attempts to develop novel therapeutic strategies. NeuroRx 2(3):447\u2013464","journal-title":"NeuroRx"},{"issue":"3","key":"5967_CR53","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/hmg\/8.3.397","volume":"8","author":"G Schilling","year":"1999","unstructured":"Schilling G et al (1999) Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin. Hum Mol Genet 8(3):397\u2013407","journal-title":"Hum Mol Genet"},{"issue":"12","key":"5967_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0049838","volume":"7","author":"LB Menalled","year":"2012","unstructured":"Menalled LB et al (2012) Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington\u2019s disease: zQ175. PLoS ONE 7(12):e49838","journal-title":"PLoS ONE"},{"issue":"12","key":"5967_CR55","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1093\/hmg\/ddy119","volume":"27","author":"LI Petrella","year":"2018","unstructured":"Petrella LI et al (2018) A whole brain longitudinal study in the YAC128 mouse model of Huntington\u2019s disease shows distinct trajectories of neurochemical, structural connectivity and volumetric changes. Hum Mol Genet 27(12):2125\u20132137","journal-title":"Hum Mol Genet"},{"issue":"24","key":"5967_CR56","doi-asserted-by":"publisher","first-page":"6182","DOI":"10.1523\/JNEUROSCI.0857-08.2008","volume":"28","author":"M Gray","year":"2008","unstructured":"Gray M et al (2008) Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice. J Neurosci 28(24):6182\u20136195","journal-title":"J Neurosci"},{"key":"5967_CR57","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1007\/s11064-008-9904-5","volume":"34","author":"T Tsang","year":"2009","unstructured":"Tsang T, Haselden J, Holmes E (2009) Metabonomic characterization of the 3-nitropropionic acid rat model of Huntington\u2019s disease. Neurochem Res 34:1261\u20131271","journal-title":"Neurochem Res"},{"key":"5967_CR58","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/978-1-59259-692-8_10","volume-title":"Mitochondrial inhibitors and neurodegenerative disorders","author":"KJ Page","year":"2000","unstructured":"Page KJ, Meldrum A, Dunnett SB (2000) The 3-nitropropionic acid model of Huntington\u2019s disease: do alterations in the expression of metabolic mRNAs predict the development of striatal pathology? Mitochondrial inhibitors and neurodegenerative disorders. Springer, pp 141\u2013156"},{"issue":"6","key":"5967_CR59","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1111\/j.1471-4159.2005.03515.x","volume":"95","author":"E Brouillet","year":"2005","unstructured":"Brouillet E et al (2005) 3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington\u2019s disease. J Neurochem 95(6):1521\u20131540","journal-title":"J Neurochem"},{"issue":"6","key":"5967_CR60","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1523\/JNEUROSCI.22-06-02174.2002","volume":"22","author":"M Garcia","year":"2002","unstructured":"Garcia M et al (2002) The mitochondrial toxin 3-nitropropionic acid induces striatal neurodegeneration via a c-Jun N-terminal kinase\/c-Jun module. J Neurosci 22(6):2174\u20132184","journal-title":"J Neurosci"},{"issue":"1","key":"5967_CR61","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1177\/1073858420972662","volume":"28","author":"C Cepeda","year":"2022","unstructured":"Cepeda C, Levine MS (2022) Synaptic dysfunction in Huntington\u2019s disease: lessons from genetic animal models. Neuroscientist 28(1):20\u201340","journal-title":"Neuroscientist"},{"issue":"7084","key":"5967_CR62","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/440600a","volume":"440","author":"N Lane","year":"2006","unstructured":"Lane N (2006) Mitochondrial disease: powerhouse of disease. Nature 440(7084):600\u2013603","journal-title":"Nature"},{"issue":"1","key":"5967_CR63","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1146\/annurev.bi.54.070185.005055","volume":"54","author":"Y Hatefi","year":"1985","unstructured":"Hatefi Y (1985) The mitochondrial electron transport and oxidative phosphorylation system. Annu Rev Biochem 54(1):1015\u20131069","journal-title":"Annu Rev Biochem"},{"issue":"3","key":"5967_CR64","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1177\/15353702221147567","volume":"248","author":"Q Wang","year":"2023","unstructured":"Wang Q et al (2023) Succinate dehydrogenase complex subunit C: role in cellular physiology and disease. Exp Biol Med Maywood 248(3):263\u2013270","journal-title":"Exp Biol Med Maywood"},{"key":"5967_CR65","doi-asserted-by":"crossref","unstructured":"Akram M (2014) Citric Acid Cycle and Role of its Intermediates in Metabolism. Cell Biochem Biophys 68:475\u2013478","DOI":"10.1007\/s12013-013-9750-1"},{"issue":"4","key":"5967_CR66","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3233\/JHD-170264","volume":"6","author":"JM Dubinsky","year":"2017","unstructured":"Dubinsky JM (2017) Towards an understanding of energy impairment in Huntington\u2019s disease brain. J Huntingtons Dis 6(4):267\u2013302","journal-title":"J Huntingtons Dis"},{"issue":"3","key":"5967_CR67","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.pbi.2013.02.007","volume":"16","author":"S Huang","year":"2013","unstructured":"Huang S, Millar AH (2013) Succinate dehydrogenase: the complex roles of a simple enzyme. Curr Opin Plant Biol 16(3):344\u2013349","journal-title":"Curr Opin Plant Biol"},{"issue":"3","key":"5967_CR68","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1111\/j.1471-4159.1993.tb03633.x","volume":"61","author":"MF Beal","year":"1993","unstructured":"Beal MF et al (1993) Age\u2010dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate. J Neurochem 61(3):1147\u20131150","journal-title":"J Neurochem"},{"issue":"8","key":"5967_CR69","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1111\/j.1399-5618.2010.00874.x","volume":"12","author":"WR Marchand","year":"2010","unstructured":"Marchand WR, Yurgelun\u2010Todd D (2010) Striatal structure and function in mood disorders: a comprehensive review. Bipolar Disord 12(8):764\u2013785","journal-title":"Bipolar Disord"},{"key":"5967_CR70","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.pneurobio.2013.04.004","volume":"106","author":"SR Subramaniam","year":"2013","unstructured":"Subramaniam SR, Chesselet M-F (2013) Mitochondrial dysfunction and oxidative stress in Parkinson\u2019s disease. Prog Neurobiol 106:17\u201332","journal-title":"Prog Neurobiol"},{"issue":"1","key":"5967_CR71","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1196\/annals.1427.018","volume":"1147","author":"SE Browne","year":"2008","unstructured":"Browne SE (2008) Mitochondria and Huntington\u2019s disease pathogenesis: insight from genetic and chemical models. Ann N Y Acad Sci 1147(1):358\u2013382","journal-title":"Ann N Y Acad Sci"},{"issue":"9","key":"5967_CR72","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1111\/febs.16640","volume":"290","author":"T Paladkong","year":"2023","unstructured":"Paladkong T et al (2023) Mechanistic roles of the neighbouring cysteine in enhancing nucleophilicity of catalytic residue in a two-cysteine succinic semialdehyde dehydrogenase. FEBS J 290(9):2449\u20132462","journal-title":"FEBS J"},{"issue":"2","key":"5967_CR73","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1042\/bj2600491","volume":"260","author":"L Hederstedt","year":"1989","unstructured":"Hederstedt L, Hed\u00e9n L-O (1989) New properties of Bacillus subtilis succinate dehydrogenase altered at the active site. The apparent active site thiol of succinate oxidoreductases is dispensable for succinate oxidation. Biochem J 260(2):491\u2013497","journal-title":"Biochem J"},{"issue":"21","key":"5967_CR74","doi-asserted-by":"publisher","first-page":"13572","DOI":"10.1016\/S0021-9258(18)92737-7","volume":"266","author":"I Schr\u00f6der","year":"1991","unstructured":"Schr\u00f6der I et al (1991) Identification of active site residues of Escherichia coli fumarate reductase by site-directed mutagenesis. J Biol Chem 266(21):13572\u201313579","journal-title":"J Biol Chem"},{"issue":"5","key":"5967_CR75","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.bbabio.2013.01.012","volume":"1827","author":"HJ Kim","year":"2013","unstructured":"Kim HJ, Winge DR (2013) Emerging concepts in the flavinylation of succinate dehydrogenase. Biochimica et Biophysica Acta (BBA)-Bioenergetics 1827(5):627\u2013636","journal-title":"Biochimica et Biophysica Acta (BBA)-Bioenergetics"},{"issue":"9","key":"5967_CR76","doi-asserted-by":"publisher","first-page":"5965","DOI":"10.1074\/jbc.M511270200","volume":"281","author":"L-S Huang","year":"2006","unstructured":"Huang L-S et al (2006) 3-Nitropropionic acid is a suicide inhibitor of mitochondrial respiration that, upon oxidation by complex II, forms a covalent adduct with a catalytic base arginine in the active site of the enzyme. J Biol Chem 281(9):5965\u20135972","journal-title":"J Biol Chem"},{"issue":"9","key":"5967_CR77","doi-asserted-by":"publisher","first-page":"3767","DOI":"10.1073\/pnas.74.9.3767","volume":"74","author":"TA Alston","year":"1977","unstructured":"Alston TA, Mela L, Bright HJ (1977) 3-Nitropropionate, the toxic substance of Indigofera, is a suicide inactivator of succinate dehydrogenase. Proc Natl Acad Sci U S A 74(9):3767\u20133771","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"5967_CR78","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1002\/hlca.201100122","volume":"94","author":"K Patora-Komisarska","year":"2011","unstructured":"Patora-Komisarska K et al (2011) Organocatalyzed Michael addition of aldehydes to nitro alkenes\u2013generally accepted mechanism revisited and revised. Helv Chim Acta 94(5):719\u2013745","journal-title":"Helv Chim Acta"},{"issue":"6","key":"5967_CR79","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1021\/acschembio.8b00225","volume":"13","author":"S Ray","year":"2018","unstructured":"Ray S et al (2018) The nitro group as a masked electrophile in covalent enzyme inhibition. ACS Chem Biol 13(6):1470\u20131473","journal-title":"ACS Chem Biol"},{"issue":"12","key":"5967_CR80","doi-asserted-by":"publisher","first-page":"5161","DOI":"10.1016\/S0021-9258(18)50574-3","volume":"254","author":"CJ Coles","year":"1979","unstructured":"Coles CJ, Edmondson DE, Singer TP (1979) Inactivation of succinate dehydrogenase by 3-nitropropionate. J Biol Chem 254(12):5161\u20135167","journal-title":"J Biol Chem"},{"issue":"1","key":"5967_CR81","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/j.1749-6632.2003.tb07538.x","volume":"993","author":"AC Scallet","year":"2003","unstructured":"Scallet AC et al (2003) 3-Nitropropionic acid inhibition of succinate dehydrogenase (complex II) activity in cultured Chinese hamster ovary cells: antagonism by L-carnitine. Ann N Y Acad Sci 993(1):305\u2013312","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"5967_CR82","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S0301-0082(99)00005-2","volume":"59","author":"E Brouillet","year":"1999","unstructured":"Brouillet E (1999) Replicating Huntington\u2019s disease phenotype in experimental animals. Prog Neurobiol 59(5):427\u2013468","journal-title":"Prog Neurobiol"},{"issue":"5","key":"5967_CR83","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1046\/j.1471-4159.1994.63051772.x","volume":"63","author":"U W\u00fcllner","year":"1994","unstructured":"W\u00fcllner U et al (1994) 3-Nitropropionic acid toxicity in the striatum. J Neurochem 63(5):1772\u20131781","journal-title":"J Neurochem"},{"key":"5967_CR84","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/978-981-96-6831-1_9","volume-title":"Deciphering the role of succinate dehydrogenase in drug discovery: SDH in drug discovery","author":"V Viswalingam","year":"2025","unstructured":"Viswalingam V, Kumar D (2025) Neurodegenerative diseases and succinate dehydrogenase: a therapeutics avenue for treatment. Deciphering the role of succinate dehydrogenase in drug discovery: SDH in drug discovery. Springer, pp 191\u2013225"},{"key":"5967_CR85","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1023\/A:1020753629477","volume":"14","author":"P Nony","year":"1999","unstructured":"Nony P et al (1999) 3-Nitropropionic acid (3-NPA) produces hypothermia and inhibits histochemical labeling of succinate dehydrogenase (SDH) in rat brain. Metab Brain Dis 14:83\u201394","journal-title":"Metab Brain Dis"},{"key":"5967_CR86","doi-asserted-by":"publisher","unstructured":"Roberts TJ (2005) 3-Nitropropionic acid model of metabolic stress. In: Read SJ, Virley D (eds) Stroke genomics. Methods in molecular medicine, vol 104. Humana Press. https:\/\/doi.org\/10.1385\/1-59259-836-6:203","DOI":"10.1385\/1-59259-836-6:203"},{"key":"5967_CR87","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/978-1-59259-692-8_7","volume-title":"Mitochondrial inhibitors and neurodegenerative disorders","author":"JW Geddes","year":"2000","unstructured":"Geddes JW, Bondada V, Pang Z (2000) Mechanisms of 3-nitropropionic acid neurotoxicity. Mitochondrial inhibitors and neurodegenerative disorders. Springer, pp 107\u2013120"},{"key":"5967_CR88","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.mito.2020.08.003","volume":"55","author":"P Pantiya","year":"2020","unstructured":"Pantiya P et al (2020) Mitochondrial abnormalities in neurodegenerative models and possible interventions: focus on Alzheimer\u2019s disease, Parkinson\u2019s disease, Huntington\u2019s disease. Mitochondrion 55:14\u201347","journal-title":"Mitochondrion"},{"issue":"11\u201312","key":"5967_CR89","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1089\/ars.2006.8.2061","volume":"8","author":"SE Browne","year":"2006","unstructured":"Browne SE, Beal MF (2006) Oxidative damage in Huntington\u2019s disease pathogenesis. Antioxid Redox Signal 8(11\u201312):2061\u20132073","journal-title":"Antioxid Redox Signal"},{"issue":"3","key":"5967_CR90","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3233\/JHD-160205","volume":"5","author":"A Kumar","year":"2016","unstructured":"Kumar A, Ratan RR (2016) Oxidative stress and Huntington\u2019s disease: the good, the bad, and the ugly. J Huntington Dis 5(3):217\u2013237","journal-title":"J Huntington Dis"},{"key":"5967_CR91","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3389\/fnmol.2019.00068","volume":"12","author":"BD Paul","year":"2019","unstructured":"Paul BD, Snyder SH (2019) Impaired redox signaling in Huntington\u2019s disease: therapeutic implications. Front Mol Neurosci 12:68","journal-title":"Front Mol Neurosci"},{"issue":"2","key":"5967_CR92","doi-asserted-by":"publisher","first-page":"41","DOI":"10.5214\/ans.0972.7531.2006.130204","volume":"13","author":"P Kumar","year":"2010","unstructured":"Kumar P et al (2010) Protective effect of antioxidants on 3-nitropropionic acid induced oxidative stress and cognitive impairment. Ann Neurosci 13(2):41\u201347","journal-title":"Ann Neurosci"},{"issue":"6","key":"5967_CR93","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1021\/acscentsci.3c01589","volume":"10","author":"M-G Kang","year":"2024","unstructured":"Kang M-G et al (2024) Mitochondrial thermogenesis can trigger heat shock response in the nucleus. ACS Cent Sci 10(6):1231\u20131241","journal-title":"ACS Cent Sci"},{"issue":"7","key":"5967_CR94","doi-asserted-by":"publisher","first-page":"513","DOI":"10.3109\/02656736.2014.971446","volume":"30","author":"I Belhadj Slimen","year":"2014","unstructured":"Belhadj Slimen I et al (2014) Reactive oxygen species, heat stress and oxidative-induced mitochondrial damage. A review. Int J Hyperthermia 30(7):513\u2013523","journal-title":"Int J Hyperthermia"},{"issue":"5","key":"5967_CR95","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s10517-020-04957-9","volume":"169","author":"I Madaeva","year":"2020","unstructured":"Madaeva I et al (2020) Heat shock protein HSP70 in oxidative stress in apnea patients. Bull Exp Biol Med 169(5):695\u2013697","journal-title":"Bull Exp Biol Med"},{"issue":"1","key":"5967_CR96","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.neuro.2008.10.007","volume":"30","author":"J Duran-Vilaregut","year":"2009","unstructured":"Duran-Vilaregut J et al (2009) Blood-brain barrier disruption in the striatum of rats treated with 3-nitropropionic acid. Neurotoxicology 30(1):136\u2013143","journal-title":"Neurotoxicology"},{"key":"5967_CR97","doi-asserted-by":"publisher","unstructured":"Sato S et al (1997) Blood-brain barrier disruption, HSP70 expression and apoptosis due to 3-nitropropionie acid, a mitochondrial toxin. Acta Neurochir Suppl 70:237\u20139. https:\/\/doi.org\/10.1007\/978-3-7091-6837-0_73","DOI":"10.1007\/978-3-7091-6837-0_73"},{"issue":"3","key":"5967_CR98","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1007\/s12640-017-9766-1","volume":"32","author":"M Jodeiri Farshbaf","year":"2017","unstructured":"Jodeiri Farshbaf M, Ghaedi K (2017) Huntington\u2019s disease and mitochondria. Neurotox Res 32(3):518\u2013529","journal-title":"Neurotox Res"},{"issue":"1","key":"5967_CR99","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-79339-2","volume":"11","author":"S Ranganayaki","year":"2021","unstructured":"Ranganayaki S et al (2021) Inhibition of mitochondrial complex II in neuronal cells triggers unique pathways culminating in autophagy with implications for neurodegeneration. Sci Rep 11(1):1483","journal-title":"Sci Rep"},{"issue":"1","key":"5967_CR100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1471-4159.2010.06741.x","volume":"114","author":"JM Oliveira","year":"2010","unstructured":"Oliveira JM (2010) Nature and cause of mitochondrial dysfunction in Huntington\u2019s disease: focusing on Huntington and the striatum. J Neurochem 114(1):1\u201312","journal-title":"J Neurochem"},{"issue":"2","key":"5967_CR101","doi-asserted-by":"publisher","first-page":"878","DOI":"10.3390\/molecules15020878","volume":"15","author":"I T\u00fanez","year":"2010","unstructured":"T\u00fanez I et al (2010) 3-Nitropropionic acid as a tool to study the mechanisms involved in Huntington\u2019s disease: past, present and future. Molecules 15(2):878\u2013916","journal-title":"Molecules"},{"issue":"12","key":"5967_CR102","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.2174\/1381612826666200113162641","volume":"26","author":"O Binvignat","year":"2020","unstructured":"Binvignat O, Olloquequi J (2020) Excitotoxicity as a target against neurodegenerative processes. Curr Pharm Des 26(12):1251\u20131262","journal-title":"Curr Pharm Des"},{"issue":"3","key":"5967_CR103","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.arcmed.2007.11.011","volume":"39","author":"AM Estrada S\u00e1nchez","year":"2008","unstructured":"Estrada S\u00e1nchez AM, Mej\u00eda-Toiber J, Massieu L (2008) Excitotoxic neuronal death and the pathogenesis of Huntington\u2019s disease. Arch Med Res 39(3):265\u2013276","journal-title":"Arch Med Res"},{"issue":"8","key":"5967_CR104","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s00702-014-1180-8","volume":"121","author":"Y Zhou","year":"2014","unstructured":"Zhou Y, Danbolt NC (2014) Glutamate as a neurotransmitter in the healthy brain. J Neural Transm 121(8):799\u2013817","journal-title":"J Neural Transm"},{"key":"5967_CR105","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.fct.2018.05.022","volume":"118","author":"HN Shalaby","year":"2018","unstructured":"Shalaby HN, El-Tanbouly DM, Zaki HF (2018) Topiramate mitigates 3-nitropropionic acid-induced striatal neurotoxicity via modulation of AMPA receptors. Food Chem Toxicol 118:227\u2013234","journal-title":"Food Chem Toxicol"},{"issue":"39","key":"5967_CR106","doi-asserted-by":"publisher","first-page":"33719","DOI":"10.1074\/jbc.M111.236521","volume":"286","author":"M Mandal","year":"2011","unstructured":"Mandal M et al (2011) Impaired \u03b1-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor trafficking and function by mutant huntingtin. J Biol Chem 286(39):33719\u201333728","journal-title":"J Biol Chem"},{"issue":"1","key":"5967_CR107","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1136\/jnnp.74.1.120","volume":"74","author":"JM Hamilton","year":"2003","unstructured":"Hamilton JM et al (2003) Behavioural abnormalities contribute to functional decline in Huntington\u2019s disease. J Neurol Neurosurg Psychiatry 74(1):120\u2013122","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"5967_CR108","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1006\/exnr.2000.7428","volume":"164","author":"J Storgaard","year":"2000","unstructured":"Storgaard J et al (2000) 3-Nitropropionic acid neurotoxicity in organotypic striatal and corticostriatal slice cultures is dependent on glucose and glutamate. Exp Neurol 164(1):227\u2013235","journal-title":"Exp Neurol"},{"issue":"2","key":"5967_CR109","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/S0306-4522(97)00389-8","volume":"84","author":"J Greene","year":"1998","unstructured":"Greene J et al (1998) 3-Nitropropionic acid exacerbates N-methyl-D-aspartate toxicity in striatal culture by multiple mechanisms. Neuroscience 84(2):503\u2013510","journal-title":"Neuroscience"},{"key":"5967_CR110","doi-asserted-by":"crossref","unstructured":"Fernandes HB, Raymond LA (2009) NMDA receptors and Huntington\u2019s disease. Biology of the NMDA receptor. Frontiers in Neuroscience. Boca Raton (FL): CRC Press\/Taylor & Francis (2):17\u201345","DOI":"10.1201\/9781420044157.ch2"},{"issue":"S1","key":"5967_CR111","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1002\/ana.410320708","volume":"32","author":"S Orrenius","year":"1992","unstructured":"Orrenius S et al (1992) Calcium ions and oxidative cell injury. Ann Neurol 32(S1):S33\u2013S42","journal-title":"Ann Neurol"},{"issue":"4","key":"5967_CR112","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/S0168-0102(97)01170-X","volume":"27","author":"H Nishino","year":"1997","unstructured":"Nishino H et al (1997) Acute 3-nitropropionic acid intoxication induces striatal astrocytic cell death and dysfunction of the blood-brain barrier: involvement of dopamine toxicity. Neurosci Res 27(4):343\u2013355","journal-title":"Neurosci Res"},{"key":"5967_CR113","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ejphar.2017.03.023","volume":"803","author":"SB Chidambaram","year":"2017","unstructured":"Chidambaram SB et al (2017) Simultaneous blockade of NMDA receptors and PARP-1 activity synergistically alleviate immunoexcitotoxicity and bioenergetics in 3-nitropropionic acid intoxicated mice: evidences from memantine and 3-aminobenzamide interventions. Eur J Pharmacol 803:148\u2013158","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"5967_CR114","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0306-4522(98)00139-0","volume":"87","author":"A Fukuda","year":"1998","unstructured":"Fukuda A et al (1998) Astrocytes are more vulnerable than neurons to cellular Ca2+ overload induced by a mitochondrial toxin, 3-nitropropionic acid. Neuroscience 87(2):497\u2013507","journal-title":"Neuroscience"},{"key":"5967_CR115","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.740966","volume":"12","author":"AM Mustafa","year":"2021","unstructured":"Mustafa AM et al (2021) Inhibition of Brain GTP cyclohydrolase I attenuates 3-nitropropionic acid-induced striatal toxicity: involvement of Mas receptor\/PI3k\/Akt\/CREB\/BDNF axis. Front Pharmacol 12:740966","journal-title":"Front Pharmacol"},{"issue":"9","key":"5967_CR116","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41580-019-0129-z","volume":"20","author":"B Bilanges","year":"2019","unstructured":"Bilanges B, Posor Y, Vanhaesebroeck B (2019) PI3K isoforms in cell signalling and vesicle trafficking. Nat Rev Mol Cell Biol 20(9):515\u2013534","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"5967_CR117","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1002\/jcp.27262","volume":"234","author":"M Jafari","year":"2019","unstructured":"Jafari M et al (2019) PI3k\/AKT signaling pathway: erythropoiesis and beyond. J Cell Physiol 234(3):2373\u20132385","journal-title":"J Cell Physiol"},{"issue":"1","key":"5967_CR118","volume":"9","author":"N Kandezi","year":"2020","unstructured":"Kandezi N et al (2020) Novel insight to neuroprotective potential of curcumin: a mechanistic review of possible involvement of mitochondrial biogenesis and PI3\/Akt\/GSK3 or PI3\/Akt\/CREB\/BDNF signaling pathways. Int J Mol Cell Med 9(1):1","journal-title":"Int J Mol Cell Med"},{"issue":"1","key":"5967_CR119","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s13311-019-00805-5","volume":"17","author":"NH Sayed","year":"2020","unstructured":"Sayed NH et al (2020) Vildagliptin attenuates Huntington\u2019s disease through activation of GLP-1 receptor\/PI3K\/Akt\/BDNF pathway in 3-nitropropionic acid rat model. Neurotherapeutics 17(1):252\u2013268","journal-title":"Neurotherapeutics"},{"key":"5967_CR120","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3389\/fnins.2018.00523","volume":"12","author":"M Verma","year":"2018","unstructured":"Verma M, Wills Z, Chu CT (2018) Excitatory dendritic mitochondrial calcium toxicity: implications for Parkinson\u2019s and other neurodegenerative diseases. Front Neurosci 12:523","journal-title":"Front Neurosci"},{"issue":"1","key":"5967_CR121","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ceca.2008.02.001","volume":"44","author":"MR Duchen","year":"2008","unstructured":"Duchen MR, Verkhratsky A, Muallem S (2008) Mitochondria and calcium in health and disease. Cell Calcium 44(1):1\u20135","journal-title":"Cell Calcium"},{"issue":"7","key":"5967_CR122","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.4103\/1673-5374.360289","volume":"18","author":"A Jurcau","year":"2023","unstructured":"Jurcau A, Jurcau CM (2023) Mitochondria in Huntington\u2019s disease: implications in pathogenesis and mitochondrial-targeted therapeutic strategies. Neural Regen Res 18(7):1472\u20131477","journal-title":"Neural Regen Res"},{"issue":"18","key":"5967_CR123","doi-asserted-by":"publisher","first-page":"3622","DOI":"10.1111\/j.1742-4658.2010.07754.x","volume":"277","author":"NB Pivovarova","year":"2010","unstructured":"Pivovarova NB, Andrews SB (2010) Calcium-dependent mitochondrial function and dysfunction in neurons. FEBS J 277(18):3622\u20133636","journal-title":"FEBS J"},{"issue":"5","key":"5967_CR124","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1046\/j.1471-4159.2003.02250.x","volume":"88","author":"TR Rosenstock","year":"2004","unstructured":"Rosenstock TR et al (2004) Mitochondrial calcium, oxidative stress and apoptosis in a neurodegenerative disease model induced by 3-nitropropionic acid. J Neurochem 88(5):1220\u20131228","journal-title":"J Neurochem"},{"issue":"3","key":"5967_CR125","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/S0306-4522(02)00097-0","volume":"112","author":"WT Lee","year":"2002","unstructured":"Lee WT, Yin HS, Shen YZ (2002) The mechanisms of neuronal death produced by mitochondrial toxin 3-nitropropionic acid: the roles of N-methyl-D-aspartate glutamate receptors and mitochondrial calcium overload. Neuroscience 112(3):707\u2013716","journal-title":"Neuroscience"},{"issue":"10","key":"5967_CR126","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1242\/jcs.00420","volume":"116","author":"XQ Wang","year":"2003","unstructured":"Wang XQ et al (2003) Apoptotic insults impair Na+, K+-ATPase activity as a mechanism of neuronal death mediated by concurrent ATP deficiency and oxidant stress. J Cell Sci 116(10):2099\u20132110","journal-title":"J Cell Sci"},{"key":"5967_CR127","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2016.00195","volume":"7","author":"PF Kinoshita","year":"2016","unstructured":"Kinoshita PF et al (2016) The influence of Na+, K+-ATPase on glutamate signaling in neurodegenerative diseases and senescence. Front Physiol 7:195","journal-title":"Front Physiol"},{"key":"5967_CR128","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1007\/s11064-008-9809-3","volume":"34","author":"P Nasr","year":"2009","unstructured":"Nasr P, Carbery T, Geddes JW (2009) N-Methyl-D-aspartate receptor antagonists have variable affect in 3-nitropropionic acid toxicity. Neurochem Res 34:490\u2013498","journal-title":"Neurochem Res"},{"issue":"3","key":"5967_CR129","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1124\/jpet.112.198341","volume":"343","author":"DA Sibarov","year":"2012","unstructured":"Sibarov DA et al (2012) Na+, K+-ATPase functionally interacts with the plasma membrane Na+, Ca2+ exchanger to prevent Ca2+ overload and neuronal apoptosis in excitotoxic stress. J Pharmacol Exp Ther 343(3):596\u2013607","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"5967_CR130","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1161\/01.RES.0000181170.87738.f3","volume":"97","author":"J Inserte","year":"2005","unstructured":"Inserte J et al (2005) Calpain-mediated impairment of Na+\/K+\u2013ATPase activity during early reperfusion contributes to cell death after myocardial ischemia. Circ Res 97(5):465\u2013473","journal-title":"Circ Res"},{"issue":"8","key":"5967_CR131","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1111\/j.1460-9568.1995.tb00689.x","volume":"7","author":"P Calabresi","year":"1995","unstructured":"Calabresi P et al (1995) Vulnerability of medium spiny striatal neurons to glutamate: role of Na+\/K+ ATPase. Eur J Neurosci 7(8):1674\u20131683","journal-title":"Eur J Neurosci"},{"issue":"3","key":"5967_CR132","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S0149-7634(96)00027-9","volume":"21","author":"CV Borlongan","year":"1997","unstructured":"Borlongan CV, Koutouzis TK, Sanberg PR (1997) 3-Nitropropionic acid animal model and Huntington\u2019 s disease. Neuroscience & Biobehavior Reviews 21(3):289\u2013293","journal-title":"Neuroscience & Biobehavior Reviews"},{"issue":"4","key":"5967_CR133","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.neuroscience.2004.09.053","volume":"129","author":"M Simard","year":"2004","unstructured":"Simard M, Nedergaard M (2004) The neurobiology of glia in the context of water and ion homeostasis. Neuroscience 129(4):877\u2013896","journal-title":"Neuroscience"},{"issue":"12","key":"5967_CR134","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1002\/glia.20848","volume":"57","author":"D Blackburn","year":"2009","unstructured":"Blackburn D et al (2009) Astrocyte function and role in Motor neuron disease: a future therapeutic target? Glia 57(12):1251\u20131264","journal-title":"Glia"},{"issue":"2","key":"5967_CR135","doi-asserted-by":"publisher","DOI":"10.3390\/cells8020184","volume":"8","author":"S Mahmoud","year":"2019","unstructured":"Mahmoud S et al (2019) Astrocytes maintain glutamate homeostasis in the CNS by controlling the balance between glutamate uptake and release. Cells 8(2):184","journal-title":"Cells"},{"issue":"1","key":"5967_CR136","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1186\/s12964-025-02341-6","volume":"23","author":"L L\u00f3pez-Molina","year":"2025","unstructured":"L\u00f3pez-Molina L et al (2025) Mitochondria from Huntington\u2019s disease striatal astrocytes are hypermetabolic and compromise neuronal branching. Cell Commun Signal 23(1):341","journal-title":"Cell Commun Signal"},{"key":"5967_CR137","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2024.106672","volume":"201","author":"C-P Chang","year":"2024","unstructured":"Chang C-P, Wu C-W, Chern Y (2024) Metabolic dysregulation in Huntington\u2019s disease: neuronal and glial perspectives. Neurobiology of Disease 201:106672","journal-title":"Neurobiology of Disease"},{"key":"5967_CR138","doi-asserted-by":"publisher","DOI":"10.1016\/j.crphar.2022.100130","volume":"3","author":"P Chandolia","year":"2022","unstructured":"Chandolia P, Rahi V, Kumar P (2022) Neuroprotective effect of silymarin against 3-Nitropropionic acid-induced neurotoxicity in rats. Current Research in Pharmacology and Drug Discovery 3:100130","journal-title":"Current Research in Pharmacology and Drug Discovery"},{"key":"5967_CR139","doi-asserted-by":"publisher","DOI":"10.1016\/j.crphar.2022.100130","volume":"3","author":"P Chandolia","year":"2022","unstructured":"Chandolia P, Rahi V, Kumar P (2022) Neuroprotective effect of silymarin against 3-nitropropionic acid-induced neurotoxicity in rats. Curr Res Pharmacol Drug Discov 3:100130. https:\/\/doi.org\/10.1016\/j.crphar.2022.100130","journal-title":"Curr Res Pharmacol Drug Discov"},{"issue":"6","key":"5967_CR140","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","volume":"44","author":"J-P Vonsattel","year":"1985","unstructured":"Vonsattel J-P et al (1985) Neuropathological classification of Huntington\u2019s disease. J Neuropathol Exp Neurol 44(6):559\u2013577","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4","key":"5967_CR141","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1097\/00005072-199704000-00013","volume":"56","author":"T Arzberger","year":"1997","unstructured":"Arzberger T et al (1997) Changes of NMDA receptor subunit (NR1, NR2B) and glutamate transporter (GLT1) mRNA expression in Huntington\u2019s disease\u2014an in situ hybridization study. J Neuropathol Exp Neurol 56(4):440\u2013454","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"5967_CR142","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.baga.2012.04.029","volume":"2","author":"AM Estrada-S\u00e1nchez","year":"2012","unstructured":"Estrada-S\u00e1nchez AM, Rebec GV (2012) Corticostriatal dysfunction and glutamate transporter 1 (GLT1) in Huntington\u2019s disease: interactions between neurons and astrocytes. Basal ganglia 2(2):57\u201366","journal-title":"Basal ganglia"},{"key":"5967_CR143","doi-asserted-by":"crossref","unstructured":"Savage CD et al (2012) NLRP3-inflammasome activating DAMPs stimulate an inflammatory response in glia in the absence of priming which contributes to brain inflammation after injury. Front Immunol Volume 3 - 2012","DOI":"10.3389\/fimmu.2012.00288"},{"issue":"4","key":"5967_CR144","doi-asserted-by":"publisher","DOI":"10.4110\/in.2018.18.e27","volume":"18","author":"JS Roh","year":"2018","unstructured":"Roh JS, Sohn DH (2018) Damage-associated molecular patterns in inflammatory diseases. Immune Netw 18(4):e27","journal-title":"Immune Netw"},{"key":"5967_CR145","volume-title":"Special issue microglia","author":"U Hanisch","year":"2002","unstructured":"Hanisch U, Kohsaka S, M\u00f6ller T (2002) Special issue microglia. Wiely-Liss, New York"},{"issue":"1","key":"5967_CR146","doi-asserted-by":"publisher","first-page":"1","DOI":"10.33160\/yam.2024.02.001","volume":"67","author":"K Nakaso","year":"2024","unstructured":"Nakaso K (2024) Roles of microglia in neurodegenerative diseases. Yonago Acta Med 67(1):1\u20138","journal-title":"Yonago Acta Med"},{"issue":"1","key":"5967_CR147","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrn2038","volume":"8","author":"ML Block","year":"2007","unstructured":"Block ML, Zecca L, Hong J-S (2007) Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 8(1):57\u201369","journal-title":"Nat Rev Neurosci"},{"issue":"21","key":"5967_CR148","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.1016\/j.neuron.2022.10.020","volume":"110","author":"RC Paolicelli","year":"2022","unstructured":"Paolicelli RC et al (2022) Microglia states and nomenclature: a field at its crossroads. Neuron 110(21):3458\u20133483","journal-title":"Neuron"},{"issue":"11","key":"5967_CR149","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1038\/nn1997","volume":"10","author":"U-K Hanisch","year":"2007","unstructured":"Hanisch U-K, Kettenmann H (2007) Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 10(11):1387\u20131394","journal-title":"Nat Neurosci"},{"key":"5967_CR150","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.physbeh.2015.12.015","volume":"155","author":"S Jamwal","year":"2016","unstructured":"Jamwal S, Kumar P (2016) Spermidine ameliorates 3-nitropropionic acid (3-NP)-induced striatal toxicity: possible role of oxidative stress, neuroinflammation, and neurotransmitters. Physiol Behav 155:180\u2013187","journal-title":"Physiol Behav"},{"issue":"21","key":"5967_CR151","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252111787","volume":"25","author":"X Li","year":"2024","unstructured":"Li X et al (2024) Neuroinflammatory proteins in Huntington\u2019s disease: insights into mechanisms, diagnosis, and therapeutic implications. Int J Mol Sci 25(21):11787","journal-title":"Int J Mol Sci"},{"issue":"2","key":"5967_CR152","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1093\/jnen\/60.2.161","volume":"60","author":"E Sapp","year":"2001","unstructured":"Sapp E et al (2001) Early and progressive accumulation of reactive microglia in the Huntington disease brain. J Neuropathol Exp Neurol 60(2):161\u2013172","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"5967_CR153","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1006\/exnr.1999.7170","volume":"159","author":"S Singhrao","year":"1999","unstructured":"Singhrao S et al (1999) Increased complement biosynthesis by microglia and complement activation on neurons in Huntington\u2019s disease. Exp Neurol 159(2):362\u2013376","journal-title":"Exp Neurol"},{"issue":"11","key":"5967_CR154","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1212\/01.wnl.0000222734.56412.17","volume":"66","author":"N Pavese","year":"2006","unstructured":"Pavese N et al (2006) Microglial activation correlates with severity in Huntington disease: a clinical and PET study. Neurology 66(11):1638\u20131643","journal-title":"Neurology"},{"key":"5967_CR155","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1088124","volume":"13","author":"Q Jia","year":"2022","unstructured":"Jia Q et al (2022) Neuroinflammation in Huntington\u2019s disease: from animal models to clinical therapeutics. Front Immunol 13:1088124","journal-title":"Front Immunol"},{"issue":"5","key":"5967_CR156","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1080\/13543784.2024.2348738","volume":"33","author":"SE Field","year":"2024","unstructured":"Field SE, Curle AJ, Barker RA (2024) Inflammation and Huntington\u2019s disease\u2013a neglected therapeutic target? Expert Opin Investig Drugs 33(5):451\u2013467","journal-title":"Expert Opin Investig Drugs"},{"key":"5967_CR157","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.bbi.2014.09.011","volume":"44","author":"K-H Chang","year":"2015","unstructured":"Chang K-H et al (2015) Plasma inflammatory biomarkers for Huntington\u2019s disease patients and mouse model. Brain Behav Immun 44:121\u2013127","journal-title":"Brain Behav Immun"},{"issue":"7","key":"5967_CR158","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1021\/pr0700753","volume":"6","author":"A Dalrymple","year":"2007","unstructured":"Dalrymple A et al (2007) Proteomic profiling of plasma in Huntington\u2019s disease reveals neuroinflammatory activation and biomarker candidates. J Proteome Res 6(7):2833\u20132840","journal-title":"J Proteome Res"},{"key":"5967_CR159","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2023.1130989","volume":"14","author":"S Hassamal","year":"2023","unstructured":"Hassamal S (2023) Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories. Front Psychiatry 14:1130989","journal-title":"Front Psychiatry"},{"issue":"1","key":"5967_CR160","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/nyas.14977","volume":"1522","author":"BS Khakh","year":"2023","unstructured":"Khakh BS, Goldman SA (2023) Astrocytic contributions to Huntington\u2019s disease pathophysiology. Ann N Y Acad Sci 1522(1):42\u201359","journal-title":"Ann N Y Acad Sci"},{"issue":"50","key":"5967_CR161","doi-asserted-by":"publisher","first-page":"18259","DOI":"10.1523\/JNEUROSCI.4008-12.2012","volume":"32","author":"J Bouchard","year":"2012","unstructured":"Bouchard J et al (2012) Cannabinoid receptor 2 signaling in peripheral immune cells modulates disease onset and severity in mouse models of Huntington\u2019s disease. J Neurosci 32(50):18259\u201318268","journal-title":"J Neurosci"},{"issue":"1","key":"5967_CR162","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1006\/nbdi.1996.0002","volume":"3","author":"AH Sharp","year":"1996","unstructured":"Sharp AH, Ross CA (1996) Neurobiology of Huntington\u2019s disease. Neurobiol Dis 3(1):3\u201315","journal-title":"Neurobiol Dis"},{"key":"5967_CR163","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2023.1094503","volume":"17","author":"TG Brown","year":"2023","unstructured":"Brown TG et al (2023) Striatal spatial heterogeneity, clustering, and white matter association of GFAP+ astrocytes in a mouse model of Huntington\u2019s disease. Front Cell Neurosci 17:1094503","journal-title":"Front Cell Neurosci"},{"key":"5967_CR164","doi-asserted-by":"publisher","unstructured":"Noor SM et al (2025) Morin hydrate: a comprehensive review on therapeutic potential in treating neurological diseases. Nutr Neurosci 29(1):55\u201379. https:\/\/doi.org\/10.1080\/1028415x.2025.2544605","DOI":"10.1080\/1028415x.2025.2544605"},{"issue":"4","key":"5967_CR165","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11011-025-01577-y","volume":"40","author":"LA Vinjavarapu","year":"2025","unstructured":"Vinjavarapu LA et al (2025) Neuroprotective effects of indole 3-carbinol against scopolamine-induced cognitive and memory impairment in rats: modulation of oxidative stress, inflammatory and cholinergic pathways. Metab Brain Dis 40(4):1\u201315","journal-title":"Metab Brain Dis"},{"issue":"5","key":"5967_CR166","doi-asserted-by":"publisher","DOI":"10.3390\/plants14050827","volume":"14","author":"Y Srikanth","year":"2025","unstructured":"Srikanth Y et al (2025) Unveiling the multifaceted pharmacological actions of indole-3-carbinol and diindolylmethane: a comprehensive review. Plants 14(5):827","journal-title":"Plants"},{"issue":"10","key":"5967_CR167","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1002\/glia.20526","volume":"55","author":"DA Simmons","year":"2007","unstructured":"Simmons DA et al (2007) Ferritin accumulation in dystrophic microglia is an early event in the development of Huntington\u2019s disease. Glia 55(10):1074\u20131084","journal-title":"Glia"},{"issue":"8","key":"5967_CR168","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1084\/jem.20080178","volume":"205","author":"M Bj\u00f6rkqvist","year":"2008","unstructured":"Bj\u00f6rkqvist M et al (2008) A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington\u2019s disease. J Exp Med 205(8):1869\u20131877","journal-title":"J Exp Med"},{"issue":"12","key":"5967_CR169","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1084\/jem.20160776","volume":"213","author":"M-H Disatnik","year":"2016","unstructured":"Disatnik M-H et al (2016) Potential biomarkers to follow the progression and treatment response of Huntington\u2019s disease. J Exp Med 213(12):2655\u20132669","journal-title":"J Exp Med"},{"key":"5967_CR170","volume":"23","author":"M Podlacha","year":"2022","unstructured":"Podlacha M et al (2022) Behavioral-and blood-based biomarkers for Huntington\u2019s disease: studies on the R6\/1 mouse model with prospects for early diagnosis and monitoring of the disease. Brain Behav Immun 23:100482","journal-title":"Brain Behav Immun"},{"key":"5967_CR171","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.116653","volume":"232","author":"PAC Valad\u00e3o","year":"2019","unstructured":"Valad\u00e3o PAC et al (2019) Inflammatory changes in peripheral organs in the BACHD murine model of Huntington\u2019s disease. Life Sci 232:116653","journal-title":"Life Sci"},{"issue":"5","key":"5967_CR172","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.etp.2008.11.002","volume":"61","author":"J Pedraza-Chaverr\u00ed","year":"2009","unstructured":"Pedraza-Chaverr\u00ed J et al (2009) ROS scavenging capacity and neuroprotective effect of alpha-mangostin against 3-nitropropionic acid in cerebellar granule neurons. Exp Toxicol Pathol 61(5):491\u2013501","journal-title":"Exp Toxicol Pathol"},{"issue":"3","key":"5967_CR173","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12781","volume":"53","author":"Y Chen","year":"2020","unstructured":"Chen Y et al (2020) The role of astrocytes in oxidative stress of central nervous system: a mixed blessing. Cell Prolif 53(3):e12781","journal-title":"Cell Prolif"},{"key":"5967_CR174","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/978-1-59259-297-5_22","volume-title":"Neuroinflammation: mechanisms and management","author":"H Hida","year":"2003","unstructured":"Hida H, Baba H, Nishino H (2003) Neuroinflammatory components of the 3-nitropropionic acid model of striatal neurodegeneration. Neuroinflammation: mechanisms and management. Springer, pp 405\u2013416"},{"key":"5967_CR175","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s12640-019-00086-y","volume":"37","author":"MS Abdelfattah","year":"2020","unstructured":"Abdelfattah MS et al (2020) Rutin and selenium co-administration reverse 3-nitropropionic acid-induced neurochemical and molecular impairments in a mouse model of Huntington\u2019s disease. Neurotox Res 37:77\u201392","journal-title":"Neurotox Res"},{"issue":"1","key":"5967_CR176","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1146\/annurev.nutr.24.012003.132446","volume":"25","author":"U Singh","year":"2005","unstructured":"Singh U, Devaraj S, Jialal I (2005) Vitamin E, oxidative stress, and inflammation. Annu Rev Nutr 25(1):151\u2013174","journal-title":"Annu Rev Nutr"},{"issue":"2b","key":"5967_CR177","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1111\/j.1476-5381.2011.01418.x","volume":"164","author":"P Kumar","year":"2011","unstructured":"Kumar P, Kalonia H, Kumar A (2011) Expression of concern: role of LOX\/COX pathways in 3-nitropropionic acid-induced Huntington\u2019s disease-like symptoms in rats: protective effect of licofelone. Br J Pharmacol 164(2b):644\u2013654","journal-title":"Br J Pharmacol"},{"issue":"1","key":"5967_CR178","volume":"2012","author":"I Lima","year":"2012","unstructured":"Lima I et al (2012) Role of prostaglandins in neuroinflammatory and neurodegenerative diseases. Mediators Inflamm 2012(1):946813","journal-title":"Mediators Inflamm"},{"issue":"9","key":"5967_CR179","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1038\/s41401-020-00558-4","volume":"42","author":"X Yang","year":"2021","unstructured":"Yang X et al (2021) Ginsenoside Rg1 exerts neuroprotective effects in 3-nitropronpionic acid-induced mouse model of Huntington\u2019s disease via suppressing MAPKs and NF-\u03baB pathways in the striatum. Acta Pharmacol Sin 42(9):1409\u20131421","journal-title":"Acta Pharmacol Sin"},{"issue":"3","key":"5967_CR180","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0928-4680(00)00053-5","volume":"7","author":"K Kannan","year":"2000","unstructured":"Kannan K, Jain SK (2000) Oxidative stress and apoptosis. Pathophysiology 7(3):153\u2013163","journal-title":"Pathophysiology"},{"key":"5967_CR181","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1007\/s10495-010-0481-0","volume":"15","author":"Y Wang","year":"2010","unstructured":"Wang Y, Qin Z-h (2010) Molecular and cellular mechanisms of excitotoxic neuronal death. Apoptosis 15:1382\u20131402","journal-title":"Apoptosis"},{"issue":"3-4","key":"5967_CR182","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1515\/REVNEURO.1997.8.3-4.223","volume":"8","author":"\u039c Dragunow","year":"1997","unstructured":"Dragunow \u039c et al (1997) Apoptosis, neurotrophic factors and neurodegeneration. Rev Neurosci 8(3\u20134):223\u2013265","journal-title":"Rev Neurosci"},{"issue":"4","key":"5967_CR183","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S0002-9343(00)00291-6","volume":"108","author":"LS Honig","year":"2000","unstructured":"Honig LS, Rosenberg RN (2000) Apoptosis and neurologic disease. Am J Med 108(4):317\u2013330","journal-title":"Am J Med"},{"issue":"19","key":"5967_CR184","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1093\/hmg\/9.19.2859","volume":"9","author":"S-H Li","year":"2000","unstructured":"Li S-H et al (2000) Intranuclear huntingtin increases the expression of caspase-1 and induces apoptosis. Hum Mol Genet 9(19):2859\u20132867","journal-title":"Hum Mol Genet"},{"issue":"12","key":"5967_CR185","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1097\/00001756-199908200-00001","volume":"10","author":"G-H Wang","year":"1999","unstructured":"Wang G-H et al (1999) Caspase activation during apoptotic cell death induced by expanded polyglutamine in N2a cells. NeuroReport 10(12):2435\u20132438","journal-title":"NeuroReport"},{"issue":"44","key":"5967_CR186","doi-asserted-by":"publisher","first-page":"28873","DOI":"10.1074\/jbc.273.44.28873","volume":"273","author":"YF Liu","year":"1998","unstructured":"Liu YF (1998) Expression of polyglutamine-expanded Huntingtin activates the SEK1-JNK pathway and induces apoptosis in a hippocampal neuronal cell line. J Biol Chem 273(44):28873\u201328877","journal-title":"J Biol Chem"},{"issue":"52","key":"5967_CR187","doi-asserted-by":"publisher","first-page":"41299","DOI":"10.1074\/jbc.M008408200","volume":"275","author":"AS Hackam","year":"2000","unstructured":"Hackam AS et al (2000) Huntingtin interacting protein 1 induces apoptosis via a novel caspase-dependent death effector domain. J Biol Chem 275(52):41299\u201341308","journal-title":"J Biol Chem"},{"issue":"1","key":"5967_CR188","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1006\/nbdi.2000.0327","volume":"8","author":"GW Kim","year":"2001","unstructured":"Kim GW, Chan PH (2001) Oxidative stress and neuronal DNA fragmentation mediate age-dependent vulnerability to the mitochondrial toxin, 3-nitropropionic acid, in the mouse striatum. Neurobiol Dis 8(1):114\u2013126","journal-title":"Neurobiol Dis"},{"issue":"5","key":"5967_CR189","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/S0361-9230(01)00761-4","volume":"57","author":"FJ Antonawich","year":"2002","unstructured":"Antonawich FJ, Fiore-Marasa SM, Parker CP (2002) Modulation of apoptotic regulatory proteins and early activation of cytochrome C following systemic 3-nitropropionic acid administration. Brain Res Bull 57(5):647\u2013649","journal-title":"Brain Res Bull"},{"issue":"1\u20132","key":"5967_CR190","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/0006-8993(95)00901-2","volume":"697","author":"CV Borlongan","year":"1995","unstructured":"Borlongan CV et al (1995) Behavioral pathology induced by repeated systemic injections of 3-nitropropionic acid mimics the motoric symptoms of Huntington\u2019s disease. Brain Res 697(1\u20132):254\u2013257","journal-title":"Brain Res"},{"issue":"7","key":"5967_CR191","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0305358","volume":"19","author":"EJ Jambi","year":"2024","unstructured":"Jambi EJ et al (2024) 6-Shogaol against 3-nitropropionic acid-induced Huntington\u2019s disease in rodents: based on molecular docking\/targeting pro-inflammatory cytokines\/NF-\u03baB-BDNF-Nrf2 pathway. PLoS One 19(7):e0305358","journal-title":"PLoS One"},{"issue":"5","key":"5967_CR192","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1007\/s10787-022-01004-z","volume":"30","author":"WW Ibrahim","year":"2022","unstructured":"Ibrahim WW, Abdel Rasheed NO (2022) Diapocynin neuroprotective effects in 3-nitropropionic acid Huntington\u2019s disease model in rats: emphasis on Sirt1\/Nrf2 signaling pathway. Inflammopharmacology 30(5):1745\u20131758","journal-title":"Inflammopharmacology"},{"issue":"9","key":"5967_CR193","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1007\/s00210-021-02106-1","volume":"394","author":"P Sharma","year":"2021","unstructured":"Sharma P, Kumar M, Bansal N (2021) Ellagic acid prevents 3-nitropropionic acid induced symptoms of Huntington\u2019s disease. Naunyn-Schmiedeberg Arch Pharmacol 394(9):1917\u20131928","journal-title":"Naunyn-Schmiedeberg Arch Pharmacol"},{"key":"5967_CR194","doi-asserted-by":"crossref","unstructured":"Vis et al (1999) 3\u2010Nitropropionic acid induces a spectrum of Huntington\u2019s disease\u2010like neuropathology in rat striatum. Neuropathol appl neurobiol 25(6): p. 513\u2013521","DOI":"10.1046\/j.1365-2990.1999.00212.x"},{"issue":"02","key":"5967_CR195","doi-asserted-by":"crossref","first-page":"242","DOI":"10.48047\/yaxvep51","volume":"53","author":"NB Etukuri","year":"2024","unstructured":"Etukuri NB, Avula PR (2024) Evaluation of biochemical and histopathological findings using hesperetin against Huntington\u2019s disease like symptoms induced by 3-Nitropropionic acid in rats. Cuest Fisioter 53(02):242\u2013252","journal-title":"Cuest Fisioter"},{"issue":"6","key":"5967_CR196","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1016\/j.neurobiolaging.2015.02.004","volume":"36","author":"A Mehrotra","year":"2015","unstructured":"Mehrotra A et al (2015) Mitochondrial modulators in experimental Huntington\u2019s disease: reversal of mitochondrial dysfunctions and cognitive deficits. Neurobiol Aging 36(6):2186\u20132200","journal-title":"Neurobiol Aging"},{"issue":"1","key":"5967_CR197","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-07181-5","volume":"15","author":"SK Alenezi","year":"2025","unstructured":"Alenezi SK (2025) Barbigerone attenuates 3-nitropropionic acid-induced Huntington\u2019s disease-like neuropathology in rats via antioxidant, anti-inflammatory, and neuroprotective mechanisms. Sci Rep 15(1):23356","journal-title":"Sci Rep"},{"issue":"1","key":"5967_CR198","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s10020-024-00917-5","volume":"30","author":"ME Noureldeen","year":"2024","unstructured":"Noureldeen ME et al (2024) Parthenolide ameliorates 3-nitropropionic acid-induced Huntington\u2019s disease-like aberrations via modulating NLRP3 inflammasome, reducing microglial activation and inducing astrocyte shifting. Mol Med 30(1):158","journal-title":"Mol Med"},{"key":"5967_CR199","unstructured":"Soni MG et al (2004) 5 \u03b2-nitropropionic acid in the diet: toxicity aspects. Rev Food Nutr Toxicity Volume 2:\u00a0p. 127"},{"key":"5967_CR200","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.biopha.2015.11.009","volume":"77","author":"SB Dhadde","year":"2016","unstructured":"Dhadde SB et al (2016) Effect of embelin against 3-nitropropionic acid-induced Huntington\u2019s disease in rats. Biomed Pharmacother 77:52\u201358","journal-title":"Biomed Pharmacother"},{"issue":"11","key":"5967_CR201","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10112866","volume":"10","author":"TH Albekairi","year":"2022","unstructured":"Albekairi TH et al (2022) Beta-boswellic acid reverses 3-nitropropionic acid-induced molecular, mitochondrial, and histopathological defects in experimental rat model of Huntington\u2019s disease. Biomedicines 10(11):2866","journal-title":"Biomedicines"},{"issue":"3","key":"5967_CR202","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.pbb.2005.10.018","volume":"82","author":"MG Tadros","year":"2005","unstructured":"Tadros MG et al (2005) Neuroprotective effect of taurine in 3-nitropropionic acid-induced experimental animal model of Huntington\u2019s disease phenotype. Pharmacol Biochem Behav 82(3):574\u2013582","journal-title":"Pharmacol Biochem Behav"},{"key":"5967_CR203","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.neuro.2014.10.004","volume":"45","author":"A Hariharan","year":"2014","unstructured":"Hariharan A et al (2014) Potential of protease inhibitor in 3-nitropropionic acid induced Huntington\u2019s disease like symptoms: mitochondrial dysfunction and neurodegeneration. Neurotoxicology 45:139\u2013148","journal-title":"Neurotoxicology"},{"issue":"5","key":"5967_CR204","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.neuro.2012.07.007","volume":"33","author":"ET Menze","year":"2012","unstructured":"Menze ET et al (2012) Potential neuroprotective effects of hesperidin on 3-nitropropionic acid-induced neurotoxicity in rats. Neurotoxicology 33(5):1265\u20131275","journal-title":"Neurotoxicology"},{"issue":"10","key":"5967_CR205","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1089\/jmf.2012.2698","volume":"16","author":"Y Binawade","year":"2013","unstructured":"Binawade Y, Jagtap A (2013) Neuroprotective effect of lutein against 3-nitropropionic acid\u2013induced Huntington\u2019s disease\u2013like symptoms: possible behavioral, biochemical, and cellular alterations. J Med Food 16(10):934\u2013943","journal-title":"J Med Food"},{"issue":"3","key":"5967_CR206","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s13596-016-0237-7","volume":"16","author":"JO Bhangale","year":"2016","unstructured":"Bhangale JO, Acharya NS, Acharya SR (2016) Protective effect of Ficus religiosa (L.) against 3-nitropropionic acid induced Huntington disease. Orient Pharm Exp Med 16(3):165\u2013174","journal-title":"Orient Pharm Exp Med"},{"key":"5967_CR207","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.toxicon.2020.05.012","volume":"183","author":"A Torabi","year":"2020","unstructured":"Torabi A et al (2020) The effect of 3-nitropropionic acid on behavioral dysfunction, neuron loss and gliosis in the brain of adult male rats: the case of prefrontal cortex, hippocampus and the cerebellum. Toxicon 183:44\u201350","journal-title":"Toxicon"},{"issue":"4","key":"5967_CR208","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1093\/ilar.48.4.356","volume":"48","author":"S Ramaswamy","year":"2007","unstructured":"Ramaswamy S, McBride JL, Kordower JH (2007) Animal models of Huntington\u2019s disease. ILAR J 48(4):356\u2013373","journal-title":"ILAR J"},{"key":"5967_CR209","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1007\/s11064-018-2615-7","volume":"43","author":"P Liu","year":"2018","unstructured":"Liu P et al (2018) Tolfenamic acid attenuates 3-nitropropionic acid-induced biochemical alteration in mice. Neurochem Res 43:1938\u20131946","journal-title":"Neurochem Res"},{"issue":"5","key":"5967_CR210","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.coph.2004.04.005","volume":"4","author":"P Goldsmith","year":"2004","unstructured":"Goldsmith P (2004) Zebrafish as a pharmacological tool: the how, why and when. Curr Opin Pharmacol 4(5):504\u2013512","journal-title":"Curr Opin Pharmacol"},{"key":"5967_CR211","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.expneurol.2017.10.004","volume":"299","author":"BD Fontana","year":"2018","unstructured":"Fontana BD et al (2018) The developing utility of zebrafish models of neurological and neuropsychiatric disorders: a critical review. Exp Neurol 299:157\u2013171","journal-title":"Exp Neurol"},{"issue":"7446","key":"5967_CR212","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/nature12111","volume":"496","author":"K Howe","year":"2013","unstructured":"Howe K et al (2013) The zebrafish reference genome sequence and its relationship to the human genome. Nature 496(7446):498\u2013503","journal-title":"Nature"},{"issue":"12","key":"5967_CR213","doi-asserted-by":"publisher","first-page":"3148","DOI":"10.1002\/jnr.24977","volume":"99","author":"A Sood","year":"2021","unstructured":"Sood A et al (2021) Glia: a major player in glutamate\u2013GABA dysregulation-mediated neurodegeneration. J Neurosci Res 99(12):3148\u20133189","journal-title":"J Neurosci Res"},{"issue":"12","key":"5967_CR214","doi-asserted-by":"publisher","first-page":"8181","DOI":"10.1007\/s11033-021-06787-y","volume":"48","author":"V Kumar","year":"2021","unstructured":"Kumar V, Singh C, Singh A (2021) Zebrafish an experimental model of Huntington\u2019s disease: molecular aspects, therapeutic targets and current challenges. Mol Biol Rep 48(12):8181\u20138194","journal-title":"Mol Biol Rep"},{"key":"5967_CR215","doi-asserted-by":"publisher","unstructured":"Santos ER (2024) A comprehensive review of secondary movement disorders. https:\/\/doi.org\/10.20944\/preprints202402.1435.v1","DOI":"10.20944\/preprints202402.1435.v1"},{"issue":"11","key":"5967_CR216","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23116089","volume":"23","author":"L G\u00f3mez-Jaramillo","year":"2022","unstructured":"G\u00f3mez-Jaramillo L et al (2022) A new perspective on Huntington\u2019s disease: how a neurological disorder influences the peripheral tissues. Int J Mol Sci 23(11):6089","journal-title":"Int J Mol Sci"},{"issue":"12","key":"5967_CR217","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.tins.2008.09.004","volume":"31","author":"E Bossy-Wetzel","year":"2008","unstructured":"Bossy-Wetzel E, Petrilli A, Knott AB (2008) Mutant huntingtin and mitochondrial dysfunction. Trends Neurosci 31(12):609\u2013616","journal-title":"Trends Neurosci"},{"key":"5967_CR218","unstructured":"Al-Kalamawey N (2013) Pathological studies on 3-nitropropionic acid as a mitochondrial toxin. The International Conference of Environmental Sciences, pp 244\u2013259"},{"issue":"11","key":"5967_CR219","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/S0047-6374(02)00084-2","volume":"123","author":"C-C Hsieh","year":"2002","unstructured":"Hsieh C-C, Papaconstantinou J (2002) The effect of aging on p38 signaling pathway activity in the mouse liver and in response to ROS generated by 3-nitropropionic acid. Mech Ageing Dev 123(11):1423\u20131435","journal-title":"Mech Ageing Dev"},{"issue":"6","key":"5967_CR220","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1097\/SHK.0b013e31816f6562","volume":"30","author":"F D\u00fcnschede","year":"2008","unstructured":"D\u00fcnschede F et al (2008) Bcl-2 upregulation after 3-nitropropionic acid preconditioning in warm rat liver ischemia. Shock 30(6):699\u2013704","journal-title":"Shock"},{"issue":"2","key":"5967_CR221","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0086589","volume":"9","author":"J-Q Zhang","year":"2014","unstructured":"Zhang J-Q et al (2014) 3-nitropropionic acid induces ovarian oxidative stress and impairs follicle in mouse. PLoS One 9(2):e86589","journal-title":"PLoS One"},{"issue":"14","key":"5967_CR222","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.4238\/2015.March.30.6","volume":"14","author":"J Zhang","year":"2015","unstructured":"Zhang J et al (2015) Protective effect of proanthocyanidin against oxidative ovarian damage induced by 3-nitropropionic acid in mice. Genet Mol Res 14(14):2484\u20132494","journal-title":"Genet Mol Res"},{"issue":"3","key":"5967_CR223","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3233\/JHD-130054","volume":"2","author":"M Abildtrup","year":"2013","unstructured":"Abildtrup M, Shattock M (2013) Cardiac dysautonomia in Huntington\u2019s disease. J Huntington Dis 2(3):251\u2013261","journal-title":"J Huntington Dis"},{"issue":"5","key":"5967_CR224","volume":"2","author":"GC Melkani","year":"2016","unstructured":"Melkani GC (2016) Huntington\u2019s disease-induced cardiac disorders affect multiple cellular pathways. React Oxygen Species 2(5):325","journal-title":"React Oxygen Species"},{"issue":"8","key":"5967_CR225","first-page":"2547","volume":"20","author":"D Zielonka","year":"2014","unstructured":"Zielonka D, Piotrowska I, Mielcarek M (2014) Cardiac dysfunction in Huntington\u2019s disease. Exp Clin Cardiol 20(8):2547\u20132554","journal-title":"Exp Clin Cardiol"},{"issue":"8","key":"5967_CR226","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004550","volume":"10","author":"M Mielcarek","year":"2014","unstructured":"Mielcarek M et al (2014) Dysfunction of the CNS-heart axis in mouse models of Huntington\u2019s disease. PLoS Genet 10(8):e1004550","journal-title":"PLoS Genet"},{"issue":"1","key":"5967_CR227","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/taap.1997.8284","volume":"148","author":"PS Lopez","year":"1998","unstructured":"Lopez PS et al (1998) Characterization of 3-nitropropionic acid-induced bradycardia in isolated atria. Toxicol Appl Pharmacol 148(1):1\u20136","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1","key":"5967_CR228","first-page":"15","volume":"12","author":"A Milutinovi\u0107","year":"2012","unstructured":"Milutinovi\u0107 A, Zorc-Pleskovi\u010d R (2012) Glycogen accumulation in cardiomyocytes and cardiotoxic effects after 3NPA treatment. Bosn J Basic Med Sci 12(1):15","journal-title":"Bosn J Basic Med Sci"},{"key":"5967_CR229","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/BF02828217","volume":"25","author":"H Zhiwei","year":"2005","unstructured":"Zhiwei H et al (2005) Chemical preconditioning by 3-nitropropionic acid reduces ischemia-reperfusion injury in rat heart. Journal of Huazhong University of Science and Technology [Medical Sciences] 25:439\u2013441","journal-title":"Journal of Huazhong University of Science and Technology [Medical Sciences]"},{"issue":"21","key":"5967_CR230","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21218314","volume":"21","author":"M Bozzi","year":"2020","unstructured":"Bozzi M, Sciandra F (2020) Molecular mechanisms underlying muscle wasting in Huntington\u2019s disease. Int J Mol Sci 21(21):8314","journal-title":"Int J Mol Sci"},{"issue":"9","key":"5967_CR231","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1212\/01.WNL.0000031791.10922.CF","volume":"59","author":"L Djousse","year":"2002","unstructured":"Djousse L et al (2002) Weight loss in early stage of Huntington\u2019s disease. Neurology 59(9):1325\u20131330","journal-title":"Neurology"},{"issue":"11","key":"5967_CR232","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22115444","volume":"22","author":"OO Gonchar","year":"2021","unstructured":"Gonchar OO et al (2021) C60 fullerene reduces 3-nitropropionic acid-induced oxidative stress disorders and mitochondrial dysfunction in rats by modulation of p53, Bcl-2 and Nrf2 targeted proteins. Int J Mol Sci 22(11):5444","journal-title":"Int J Mol Sci"},{"key":"5967_CR233","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2023.153542","volume":"492","author":"K Ramakrishna","year":"2023","unstructured":"Ramakrishna K et al (2023) Indole-3-carbinol ameliorated the thioacetamide-induced hepatic encephalopathy in rats. Toxicology 492:153542","journal-title":"Toxicology"},{"issue":"1","key":"5967_CR234","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1186\/s12864-023-09493-0","volume":"24","author":"M Ran","year":"2023","unstructured":"Ran M et al (2023) Exploring right ovary degeneration in duck and goose embryos by histology and transcriptome dynamics analysis. BMC Genomics 24(1):389","journal-title":"BMC Genomics"},{"key":"5967_CR235","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2023.1319308","volume":"16","author":"W Meng","year":"2023","unstructured":"Meng W (2023) Application and research progress of avian models in neuroscience. Front Mol Neurosci 16:1319308","journal-title":"Front Mol Neurosci"},{"key":"5967_CR236","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3389\/fnmol.2012.00032","volume":"5","author":"VM Cassone","year":"2012","unstructured":"Cassone VM, Westneat DF (2012) The bird of time: cognition and the avian biological clock. Front Mol Neurosci 5:32","journal-title":"Front Mol Neurosci"},{"issue":"5","key":"5967_CR237","doi-asserted-by":"publisher","DOI":"10.1016\/j.psj.2023.102606","volume":"102","author":"D Jiang","year":"2023","unstructured":"Jiang D et al (2023) Ferritin heavy chain participated in ameliorating 3-nitropropionic acid-induced oxidative stress and apoptosis of goose follicular granulosa cells. Poult Sci 102(5):102606","journal-title":"Poult Sci"},{"issue":"5","key":"5967_CR238","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20180274","volume":"38","author":"B Kang","year":"2018","unstructured":"Kang B et al (2018) Effect of 3-nitropropionic acid inducing oxidative stress and apoptosis of granulosa cells in geese. Biosci Rep 38(5):BSR20180274","journal-title":"Biosci Rep"},{"key":"5967_CR239","doi-asserted-by":"publisher","DOI":"10.1093\/jas\/skad301","volume":"101","author":"D Jiang","year":"2023","unstructured":"Jiang D et al (2023) Effects of exogenous spermidine on autophagy and antioxidant capacity in ovaries and granulosa cells of Sichuan white geese. J Anim Sci 101:skad301","journal-title":"J Anim Sci"},{"key":"5967_CR240","doi-asserted-by":"publisher","first-page":"1292984","DOI":"10.3389\/fmicb.2023.1292984","volume":"14","author":"Z Wang","year":"2024","unstructured":"Wang Z et al (2024) Spermidine improves the antioxidant capacity and morphology of intestinal tissues and regulates intestinal microorganisms in Sichuan white geese. Front Microbiol 14:1292984","journal-title":"Front Microbiol"},{"issue":"13","key":"5967_CR241","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.lfs.2006.12.013","volume":"80","author":"I T\u00fanez","year":"2007","unstructured":"T\u00fanez I et al (2007) Effect of testosterone on oxidative stress and cell damage induced by 3-nitropropionic acid in striatum of ovariectomized rats. Life Sci 80(13):1221\u20131227","journal-title":"Life Sci"},{"issue":"8","key":"5967_CR242","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1134\/S0362119716080120","volume":"42","author":"A Stavrovskaya","year":"2016","unstructured":"Stavrovskaya A et al (2016) Experience of experimental modelling of Huntington\u2019s disease. Hum Physiol 42(8):898\u2013904","journal-title":"Hum Physiol"},{"issue":"2","key":"5967_CR243","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.neulet.2010.06.020","volume":"480","author":"ZK Binienda","year":"2010","unstructured":"Binienda ZK et al (2010) Assessment of 3-nitropropionic acid-evoked peripheral neuropathy in rats: neuroprotective effects of acetyl-l-carnitine and resveratrol. Neurosci Lett 480(2):117\u2013121","journal-title":"Neurosci Lett"},{"issue":"4","key":"5967_CR244","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.tibs.2017.01.003","volume":"42","author":"A Bezawork-Geleta","year":"2017","unstructured":"Bezawork-Geleta A et al (2017) Mitochondrial complex II: at the crossroads. Trends Biochem Sci 42(4):312\u2013325","journal-title":"Trends Biochem Sci"},{"issue":"1","key":"5967_CR245","first-page":"174","volume":"1053","author":"Z Binienda","year":"2005","unstructured":"Binienda Z et al (2005) L-carnitine and neuroprotection in the animal model of mitochondrial dysfunction. Ann N Y Acad Sci 1053(1):174\u2013182","journal-title":"Ann N Y Acad Sci"},{"issue":"7","key":"5967_CR246","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1083\/jcb.201803152","volume":"217","author":"G Yellen","year":"2018","unstructured":"Yellen G (2018) Fueling thought: management of glycolysis and oxidative phosphorylation in neuronal metabolism. J Cell Biol 217(7):2235\u20132246","journal-title":"J Cell Biol"},{"issue":"4","key":"5967_CR247","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ajme.2017.09.001","volume":"54","author":"O Ighodaro","year":"2018","unstructured":"Ighodaro O, Akinloye O (2018) First line defence antioxidants-superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): their fundamental role in the entire antioxidant defence grid. Alexandria J Med 54(4):287\u2013293","journal-title":"Alexandria J Med"},{"issue":"10","key":"5967_CR248","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.2174\/13816128113199990462","volume":"20","author":"N Vijay","year":"2014","unstructured":"Vijay N, Morris ME (2014) Role of monocarboxylate transporters in drug delivery to the brain. Curr Pharm Des 20(10):1487\u20131498","journal-title":"Curr Pharm Des"},{"key":"5967_CR249","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/978-1-59259-692-8_3","volume-title":"Mitochondrial inhibitors and neurodegenerative disorders","author":"NC Reynolds","year":"2000","unstructured":"Reynolds NC, Lin W (2000) The neurochemistry of 3-nitropropionic acid. In: Sanberg PR, Nishino H, Borlongan CV (eds) Mitochondrial inhibitors and neurodegenerative disorders. Humana Press, Totowa, NJ, pp 35\u201349"},{"issue":"1","key":"5967_CR250","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/j.1749-6632.2001.tb03647.x","volume":"939","author":"A Scallet","year":"2001","unstructured":"Scallet A et al (2001) Biomarkers of 3\u2010nitropropionic acid (3\u2010NPA)\u2010induced mitochondrial dysfunction as indicators of neuroprotection. Ann N Y Acad Sci 939(1):381\u2013392","journal-title":"Ann N Y Acad Sci"},{"key":"5967_CR251","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.biopha.2018.06.079","volume":"105","author":"RCSR Danduga","year":"2018","unstructured":"Danduga RCSR et al (2018) Neuroprotective activity of tetramethylpyrazine against 3-nitropropionic acid induced Huntington\u2019s disease-like symptoms in rats. Biomed Pharmacother 105:1254\u20131268","journal-title":"Biomed Pharmacother"},{"key":"5967_CR252","doi-asserted-by":"publisher","DOI":"10.4137\/IJTR.S8158","volume":"5","author":"V-D La Cruz","year":"2012","unstructured":"La Cruz V-D, Carrillo-Mora P, Santamar\u00eda A (2012) Quinolinic acid, an endogenous molecule combining excitotoxicity, oxidative stress and other toxic mechanisms. Int J Tryptophan Res 5:IJTR. S8158","journal-title":"Int J Tryptophan Res"},{"key":"5967_CR253","first-page":"1","volume-title":"Handbook of neurotoxicity","author":"JI Addae","year":"2021","unstructured":"Addae JI, Stone TW (2021) Quinolinic acid and related excitotoxins: mechanisms of neurotoxicity and disease relevance. Handbook of neurotoxicity. pp 1\u201322"},{"key":"5967_CR254","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1385\/MN:31:1-3:003","volume":"31","author":"Q Wang","year":"2005","unstructured":"Wang Q et al (2005) Kainic acid-mediated excitotoxicity as a model for neurodegeneration. Mol Neurobiol 31:3\u201316","journal-title":"Mol Neurobiol"},{"key":"5967_CR255","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/978-1-59259-692-8_15","volume-title":"Mitochondrial inhibitors and neurodegenerative disorders","author":"TJ Bazzett","year":"2000","unstructured":"Bazzett TJ, Albin RL, Becker JB (2000) Malonic acid and the chronic administration model of excitotoxicity. Mitochondrial inhibitors and neurodegenerative disorders. Springer, pp 219\u2013231"},{"issue":"11","key":"5967_CR256","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1002\/mds.25159","volume":"27","author":"Z Guo","year":"2012","unstructured":"Guo Z et al (2012) Striatal neuronal loss correlates with clinical motor impairment in Huntington\u2019s disease. Mov Disord 27(11):1379\u20131386","journal-title":"Mov Disord"},{"issue":"10","key":"5967_CR257","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1111\/j.1745-7254.2006.00410.x","volume":"27","author":"L-h Wang","year":"2006","unstructured":"Wang L-h, Qin Z-h (2006) Animal models of Huntington\u2019s disease: implications in uncovering pathogenic mechanisms and developing therapies. Acta Pharmacol Sin 27(10):1287\u20131302","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"5967_CR258","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.brainres.2003.09.049","volume":"994","author":"JA Saydoff","year":"2003","unstructured":"Saydoff JA et al (2003) Oral uridine pro-drug PN401 decreases neurodegeneration, behavioral impairment, weight loss and mortality in the 3-nitropropionic acid mitochondrial toxin model of Huntington\u2019s disease. Brain Res 994(1):44\u201354","journal-title":"Brain Res"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05967-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-05967-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05967-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T07:02:51Z","timestamp":1780124571000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-05967-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":258,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5967"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-05967-w","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"17 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors have permitted the publication of the article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"662"}}